GO:1990448 exon-exon junction complex binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990448 (exon-exon junction complex binding) is a molecular function describing the binding of a protein to the exon-exon junction complex (EJC), a multiprotein assembly deposited by the spliceosome ~20-24 nucleotides upstream of mRNA exon-exon junctions.
• The EJC is a core component of spliced messenger ribonucleoproteins (mRNPs) and serves as a binding platform for factors controlling mRNA export, translation, and nonsense-mediated mRNA decay (NMD).
• Core EJC components include the heterotetramer EIF4A3, RBM8A, MAGOH, and CASC3, plus peripheral factors such as PYM1, UPF1, UPF2, and UPF3B that interact with the complex.
• EJC binding shapes the transcriptome by repressing recursive splicing, influencing m6A deposition, and limiting non-canonical EJC occupancy in a gene-architecture-dependent manner.
• Dysregulation of EJC components and their binding partners is linked to cancer, neurodevelopmental disorders, and neurological disease.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of EJC binding in mRNA metabolism and disease.
Description
GO:1990448, exon-exon junction complex binding, is a molecular function term in the Gene Ontology that describes the selective interaction of a protein with the exon-exon junction complex (EJC). The EJC is a multiprotein assembly deposited by the spliceosome approximately 20-24 nucleotides upstream of exon-exon junctions on newly spliced mRNA, where it acts as a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. Because the EJC sits at the interface of splicing, mRNA packaging, and transcript quality control, proteins that bind it are central to post-transcriptional gene regulation. Researchers study GO:1990448 to understand how mRNP composition is established and remodeled, how mRNA fate decisions are made, and how disruption of these interactions contributes to disease. The function is experimentally defined by binding assays, crosslinking and immunoprecipitation, and structural studies that map direct contacts between EJC subunits and their partners. In this article we synthesize the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanism, key genes, disease links, and CRISPR-based methods relevant to GO:1990448.
exon-exon junction complex binding At A Glance
| GO ID | GO:1990448 |
|---|---|
| GO term | exon-exon junction complex binding |
| Ontology | molecular_function |
| Synonym | EJC binding |
| Definition | Binding to an exon-exon junction complex, a protein complex deposited by the spliceosome upstream of messenger RNA exon-exon junctions; the EJC provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. |
| Major function | Recruitment of proteins to spliced mRNPs for mRNA export, translation, and nonsense-mediated mRNA decay. |
| Core EJC subunits | EIF4A3, RBM8A, MAGOH, CASC3. |
| Peripheral binding partners | PYM1, UPF1, UPF2, UPF3B, and other mRNP factors. |
| Related processes | mRNA export, nonsense-mediated mRNA decay, recursive splicing repression, m6A epitranscriptome shaping. |
What Is GO:1990448?
In our own words, GO:1990448 (exon-exon junction complex binding) is the molecular function of physically and selectively binding to the exon-exon junction complex, a protein complex deposited by the spliceosome upstream of messenger RNA exon-exon junctions. This binding event is not merely a static interaction; it positions the bound protein within a larger mRNP network that provides a platform for mRNA export and nonsense-mediated mRNA decay. The term therefore captures the recognition of the EJC as a substrate or docking site by proteins such as NMD factors, export adaptors, and regulatory kinases.
Why Is exon-exon junction complex binding Important in Cell Biology?
GO:1990448 is important because the exon-exon junction complex is a central hub of post-transcriptional gene regulation, and the proteins that bind it determine whether an mRNA is exported, translated, or degraded. The EJC is deposited during splicing and remains associated with mRNA as it travels to the cytoplasm, where it recruits NMD factors and other regulators. Consequently, EJC binding influences transcriptome-wide mRNA stability and protein output, and its dysregulation has been linked to cancer, neurodevelopmental disorders, and neurological disease. Understanding this molecular function therefore provides mechanistic insight into gene expression control and identifies candidate targets for therapeutic intervention.
• Defines how spliced mRNPs recruit NMD factors and export adaptors, directly influencing mRNA fate.
• Shapes the transcriptome by repressing recursive splicing and limiting non-canonical EJC occupancy.
• Influences m6A epitranscriptome deposition and downstream RNA regulation.
• Core EJC components are essential for embryonic development and tissue homeostasis.
• Mutations in EJC components and binding partners are associated with neurodevelopmental and neurological phenotypes.
• EJC binding is relevant to cancer biology through effects on mRNA stability and translation.
• Provides a mechanistic entry point for understanding NMD-linked genetic disease.
• Enables design of CRISPR models to test causality of EJC-binding proteins.
• Supports development of RNA-targeted and mRNP-directed therapeutic strategies.
• Connects splicing, export, translation, and decay into a single regulatory network.
Molecular Mechanism of exon-exon junction complex binding
Spliceosome-dependent EJC deposition
In simple terms: The EJC is placed on mRNA right after splicing, near where two exons were joined.
The exon-exon junction complex is deposited by the spliceosome upstream of exon-exon junctions during pre-mRNA splicing, approximately 20-24 nucleotides from the junction. This deposition creates the binding site recognized by proteins that carry out GO:1990448. The core EJC is a heterotetramer composed of EIF4A3, RBM8A, MAGOH, and CASC3, which together form the platform for peripheral factor recruitment.
Recognition and direct binding by EJC-interacting proteins
In simple terms: Specific proteins dock onto the EJC, much like a key fitting a lock.
Proteins that carry out GO:1990448 bind the EJC through defined interaction surfaces on core subunits. Structural studies have revealed how EJC components present binding interfaces for partners such as NMD factors and export adaptors. Comprehensive mapping in Drosophila has shown that EJC binding sites are widespread and that EJC deposition is a universal feature of spliced mRNPs.
Recruitment of NMD and export machinery
In simple terms: Once proteins bind the EJC, they can call in the machinery that moves or destroys the mRNA.
The EJC provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. Binding of NMD factors such as UPF1, UPF2, and UPF3B to the EJC is a key step in NMD activation. Peripheral factors including PYM1 modulate EJC occupancy and thereby tune mRNA expression in a gene-architecture-dependent manner.
Regulation of EJC occupancy and composition
In simple terms: The EJC is not static; its composition and how long it stays on mRNA can change.
EJC occupancy is dynamically regulated, with factors such as PYM1 limiting non-canonical EJC binding and influencing mRNA expression. EJC binding also intersects with the m6A epitranscriptome, shaping how m6A marks are deposited and interpreted. These regulatory layers ensure that EJC-dependent decisions are context-dependent and gene-specific.
Functional consequences for mRNA fate
In simple terms: What binds the EJC helps decide whether an mRNA is used, stored, or destroyed.
EJC binding influences mRNA export, translation efficiency, and decay, thereby shaping the transcriptome and proteome. Repression of recursive splicing by the EJC further demonstrates how EJC binding contributes to transcriptome integrity. Together, these outcomes place GO:1990448 at the center of post-transcriptional gene regulation.
Key Genes Involved in GO:1990448 exon-exon junction complex binding
The following genes encode core EJC subunits and peripheral binding partners relevant to GO:1990448, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF4A3 | Core EJC ATPase/RNA helicase subunit | Central to EJC assembly and binding platform function |
| RBM8A | Core EJC subunit (Y14) | Required for EJC integrity and NMD |
| MAGOH | Core EJC subunit | Stabilizes EJC and interacts with RBM8A |
| CASC3 | Core EJC subunit (MLN51) | Peripheral EJC component influencing mRNP composition |
| PYM1 | EJC-associated factor | Limits non-canonical EJC occupancy and tunes mRNA expression |
| UPF1 | NMD factor | Binds EJC-associated mRNPs to trigger NMD |
| UPF2 | NMD factor | Interacts with EJC-bound UPF1 in NMD |
| UPF3B | NMD factor | EJC-associated NMD regulator |
| RNPS1 | EJC-associated splicing/NMD factor | Modulates EJC-dependent mRNA regulation |
| SAP18 | EJC-associated factor | Part of EJC-linked regulatory complexes |
| SRRT | EJC-associated factor | Contributes to EJC-dependent mRNA processing |
| DDX39B | Export adaptor | Links EJC-bound mRNPs to export |
| NXF1 | Export receptor | Functions in EJC-dependent mRNA export |
| ALYREF | Export adaptor | Interacts with EJC-associated mRNPs |
| SMG1 | NMD kinase | Phosphorylates UPF1 in EJC-dependent NMD |
| SMG5 | NMD factor | Functions downstream of EJC binding in NMD |
| SMG7 | NMD factor | Functions downstream of EJC binding in NMD |
How Is exon-exon junction complex binding Regulated?
EJC binding is regulated at multiple levels. PYM1 limits non-canonical EJC occupancy in a gene-architecture-dependent manner, thereby tuning mRNA expression. The EJC also shapes the m6A epitranscriptome, indicating cross-talk between EJC binding and RNA modification machinery. In addition, EJC composition and occupancy are influenced by splicing efficiency and transcript architecture, which determine where and how stably the complex is deposited. These regulatory mechanisms ensure that GO:1990448-dependent processes are responsive to cellular context.
exon-exon junction complex binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RBM8A | Neurodevelopmental and neurological phenotypes | Knockout and point-mutation cell models |
| EIF4A3 | Cancer and developmental disorders | Knockout and overexpression models |
| UPF1 | NMD-linked disease and cancer | Knockout and knock-in models |
| UPF3B | Neurodevelopmental disorders | Point-mutation and knockout models |
| PYM1 | mRNA expression regulation | Overexpression and knockout models |
EJC components in neurodevelopmental and neurological disorders
Core EJC components and their binding partners have been implicated in central nervous system development and disease. Mutations affecting EJC function can disrupt mRNA metabolism in neurons, contributing to neurological phenotypes. Because the EJC is essential for NMD and mRNA export, its dysfunction may broadly affect neuronal gene expression.
EJC binding and cancer
Dysregulation of EJC components and EJC-dependent mRNA regulation has been linked to cancer. Altered EJC binding can change the stability and translation of oncogenic or tumor-suppressive transcripts, influencing cell proliferation and survival. Targeting EJC-dependent pathways is therefore an area of active investigation.
NMD-linked genetic disease
The EJC is a key platform for nonsense-mediated mRNA decay, and proteins that bind it are directly involved in NMD. Disruption of EJC-NMD factor interactions can lead to aberrant stabilization of premature-termination-codon-containing transcripts, with consequences for genetic disease. Understanding GO:1990448 helps explain genotype-phenotype relationships in NMD-associated disorders.
From exon-exon junction complex binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an EJC-binding protein alter mRNA stability? | CRISPR knockout cell line |
| Does a disease-associated point mutation affect EJC binding? | CRISPR point-mutation knock-in |
| Where does a protein bind the EJC in cells? | Endogenous tagged knock-in |
| Does overexpression of an EJC partner change transcriptome? | CRISPR overexpression model |
| Which transcripts depend on EJC binding for export? | Knockout plus RNA-seq |
| Does EJC binding regulate NMD targets? | Knockout plus NMD reporter assays |
How to Study the exon-exon junction complex binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA abundance and splicing changes | Transcriptome-wide effects of EJC binding loss |
| CLIP-seq | Protein-RNA binding sites | Mapping EJC occupancy |
| Affinity proteomics | Protein-protein interactions | Defining EJC interactome |
| NMD reporter assay | Nonsense-mediated decay activity | Testing EJC-dependent NMD |
| Polysome profiling | Translation efficiency | Assessing EJC effects on translation |
| Structural biology | Binding interfaces | Understanding EJC-partner contacts |
| CRISPR knockout | Gene function loss | Causal testing of EJC-binding genes |
| CRISPR knock-in | Tagged or mutant protein expression | Localizing and testing EJC binding |
RNA-seq and transcriptome analysis
RNA-seq is used to measure how loss or gain of EJC binding changes mRNA abundance, splicing, and isoform usage. Such experiments can reveal recursive splicing defects and transcriptome-wide consequences of altered EJC occupancy. Combining RNA-seq with knockout models provides causal evidence for GO:1990448-related gene function.
Crosslinking and immunoprecipitation (CLIP) mapping
CLIP-based methods map EJC binding sites transcriptome-wide and have revealed universal EJC deposition in Drosophila. These approaches identify where EJC components and their partners contact RNA and how binding is distributed across transcripts. They are essential for defining the RNA context of GO:1990448.
Proteomics and interactome analysis
Affinity purification and mass spectrometry identify proteins that co-purify with the EJC, defining the binding network relevant to GO:1990448. Structural studies complement these data by revealing direct interaction interfaces. Together, these methods distinguish core subunits from peripheral binding partners.
NMD and translation assays
NMD reporter assays and polysome profiling measure the functional consequences of EJC binding on mRNA decay and translation. These assays link molecular binding events to changes in gene expression output. They are particularly useful for testing disease-associated variants.
How CRISPR Can Be Used to Study GO:1990448 exon-exon junction complex binding
Knockout
CRISPR knockout of EJC components or their binding partners is used to test loss-of-function phenotypes in mRNA export, NMD, and transcriptome stability. Knockout cell lines can be combined with RNA-seq to identify transcripts whose regulation depends on GO:1990448. This approach provides causal evidence for gene function in EJC biology.
Point Mutation
CRISPR point-mutation knock-in enables testing of disease-associated variants that may alter EJC binding affinity or specificity. Such models are valuable for distinguishing binding-dependent from binding-independent functions. They also help validate structural predictions about EJC interaction interfaces.
Knock-in
Tagged knock-in of EJC components allows endogenous localization and interaction studies without overexpression artifacts. Fluorescent or affinity tags can be introduced to track EJC dynamics in live cells. This approach supports mapping of EJC binding sites and complex composition.
Overexpression
CRISPR-based overexpression of EJC-binding proteins is used to test gain-of-function effects on mRNA expression and NMD. Overexpression can reveal dominant effects and saturate binding pathways. It complements knockout studies by probing the opposite direction of regulation.
How EDITGENE Supports exon-exon junction complex binding Research
Researchers studying exon-exon junction complex binding-related genes often need to determine whether a candidate gene is causally involved in mRNA metabolism, NMD, or disease. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point-mutation, knock-in, and overexpression studies of EJC components and their binding partners.
Contact EDITGENE today to design your custom CRISPR model for exon-exon junction complex binding research.
Frequently Asked Questions About exon-exon junction complex binding
What is GO:1990448 exon-exon junction complex binding?
GO:1990448 is a molecular function term describing the binding of a protein to the exon-exon junction complex, a multiprotein assembly deposited by the spliceosome upstream of mRNA exon-exon junctions.
What genes are involved in exon-exon junction complex binding?
Core genes include EIF4A3, RBM8A, MAGOH, and CASC3, with peripheral partners such as PYM1, UPF1, UPF2, and UPF3B.
What is the exon-exon junction complex?
The EJC is a protein complex deposited by the spliceosome upstream of exon-exon junctions that provides a binding platform for mRNA export and nonsense-mediated mRNA decay factors.
How does the EJC regulate mRNA export?
The EJC recruits export adaptors and receptors that facilitate transport of spliced mRNPs from the nucleus to the cytoplasm.
What is the role of EJC binding in nonsense-mediated mRNA decay?
Binding of NMD factors such as UPF1, UPF2, and UPF3B to the EJC is a key step in activating nonsense-mediated mRNA decay.
Which diseases are linked to EJC components?
EJC components and their binding partners have been linked to cancer, neurodevelopmental disorders, and neurological disease.
How can CRISPR be used to study EJC binding?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of EJC-binding genes in mRNA metabolism and disease.
What methods map EJC binding sites?
CLIP-based methods map EJC binding sites transcriptome-wide and have shown universal EJC deposition in Drosophila.
Does the EJC influence m6A RNA modification?
Yes, the EJC shapes the m6A epitranscriptome, linking EJC binding to RNA modification pathways.
What is PYM1 and how does it affect EJC binding?
PYM1 limits non-canonical EJC occupancy in a gene-architecture-dependent manner to tune mRNA expression.
Conclusion
GO:1990448 exon-exon junction complex binding defines a central molecular function in post-transcriptional gene regulation, linking splicing to mRNA export, translation, and nonsense-mediated decay. Core EJC subunits and peripheral partners such as PYM1, UPF1, UPF2, and UPF3B form a dynamic binding network that shapes the transcriptome and is implicated in cancer and neurological disease. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide the causal tools needed to dissect this function and its disease relevance.
References
- 1. Yang X et al.. 2022. Exon junction complex shapes the m(6)A epitranscriptome.. Nat Commun 13(1):7904 PMID: 36550132
- 2. Schlautmann LP et al.. 2020. A Day in the Life of the Exon Junction Complex.. Biomolecules 10(6) PMID: 32517083
- 3. Morillo L et al.. 2023. Comprehensive mapping of exon junction complex binding sites reveals universal EJC deposition in Drosophila.. BMC Biol 21(1):246 PMID: 37936138
- 4. Asthana S et al.. 2022. The Physiological Roles of the Exon Junction Complex in Development and Diseases.. Cells 11(7) PMID: 35406756
- 5. Gerbracht JV et al.. 2018. The exon junction complex: structural insights into a faithful companion of mammalian mRNPs.. Biochem Soc Trans 46(1):153-161 PMID: 29351963
- 6. Blazquez L et al.. 2018. Exon Junction Complex Shapes the Transcriptome by Repressing Recursive Splicing.. Mol Cell 72(3):496-509.e9 PMID: 30388411
- 7. Sanjeev M et al.. 2025. PYM1 limits non-canonical Exon Junction Complex occupancy in a gene architecture dependent manner to tune mRNA expression.. Nat Commun 16(1):8138 PMID: 40885765
- 8. Bartkowska K et al.. 2018. Roles of the exon junction complex components in the central nervous system: a mini review.. Rev Neurosci 29(8):817-824 PMID: 29791316
